- Coordinator
- Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I Sunyer, Spain
- Runs
- 1 November 2025 to 31 October 2029
- Status
- Running
- EU funding
- €3.7m
- Total cost
- —
- Partners
- 23 organisations in 10 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101227384
What the project is doing
In the project's own words, from its summary on CORDIS.
Anti-IgLON5 disease is a recently described encephalopathy associated with a variety of neurological symptoms that can be life-threating. The clinical course is mainly chronic and the response to immunotherapies is suboptimal. The hallmark of the disease is the presence of antibodies against IgLON5, a cell adhesion molecule predominantly expressed on the neuronal membrane. Surprisingly, neuropathological findings on autopsies revealed the presence of an atypical neuronal brainstem tauopathy, establishing a link between neurodegeneration and IgLON5 antibodies.
IGNITION aims to establish an innovative, interdisciplinary doctoral training program to foster the next generation of scientists at the interface of neuroinflammation and neurodegeneration. The unique program will train 13 Doctoral Candidates across four key objectives: 1) addressing clinical challenges in diagnosing and managing anti-IgLON5 disease, 2) investigating the role of neuroinflammation in neurodegeneration, 3) developing animal models for therapeutic testing, and 4) analysing the function of IgLON5 in health and disease.
These objectives will be pursued using cutting-edge molecular, cellular, and in vivo techniques, offering a comprehensive research training experience with the support of leading biotech and diagnostic companies. IGNITION will advance our understanding of the mechanisms behind anti-IgLON5 disease, contributing to scientific innovation and providing tools for improved diagnosis and prognosis. The gained insights will extend to the broader field of neurodegeneration, offering potential breakthroughs for other tauopathies, including Alzheimer’s and Parkinson’s disease.
Through its research and training activities, IGNITION will foster scientific excellence, increase disease awareness, and provide societal and economic benefits through the development of new diagnostic and therapeutic strategies across Europe.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I Sunyer | Barcelona | Spain | Coordinator |
| Medizinische Universitaet Wien | Wien | Austria | Participant |
| Argen-X | Zwijnaarde | Belgium | Associatedpartner |
| Christian-Albrechts-Universitaet Zu Kiel | Kiel | Germany | Associatedpartner |
| Euroimmun Medizinische Labordiagnostika AG | Lubeck | Germany | Associatedpartner |
| Gesellschaft zur Förderung der Lebenswissenschaften Heidelberg GmbH | Heidelberg | Germany | Associatedpartner |
| Sonja Noss | Wiesbaden | Germany | Associatedpartner |
| Universitatsklinikum Jena | Jena | Germany | Participant |
| Universitatsklinikum Schleswig-Holstein | Lübeck | Germany | Participant |
| Biosystems SA | Barcelona | Spain | Participant |
| Carl Zeiss Iberia | Tres Cantos | Spain | Associatedpartner |
| Fundacio Institut De Ciencies Fotoniques | Castelldefels | Spain | Associatedpartner |
| Hospital Clinic De Barcelona | Barcelona | Spain | Associatedpartner |
| Panlab Slu | Cornella de Llobregat | Spain | Associatedpartner |
| Universitat De Barcelona | Barcelona | Spain | Associatedpartner |
| Centre National De La Recherche Scientifique CNRS | Paris | France | Participant |
| Universite De Bordeaux | Bordeaux | France | Associatedpartner |
| Fondazione Human Technopole | Milano | Italy | Participant |
| Universita Humanitas | Pieve Emanuele | Italy | Associatedpartner |
| Erasmus Universitair Medisch Centrum Rotterdam | Rotterdam | Netherlands | Participant |
| Politechnika Wroclawska | Wroclaw | Poland | Participant |
| Universidade De Coimbra | Coimbra | Portugal | Participant |
| Encephalitis Support Group | Malton | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI